
COVID-19 Research
Changing the Course of a Pandemic
The work of researchers at Children’s and Emory has helped change the course of the COVID-19 pandemic. We were on the forefront of COVID-19 research that allowed for the gradual return to everyday life by leading to authorization of pediatric vaccines, availability of at-home tests, authorization of new drugs for treatment, assessing antibodies and variants, and identification of potential biomarkers. These discoveries have helped. Kids are back in the classroom and participating in social activities in person once again—and it was all made possible, in part, by discoveries made in our labs and clinics.
-
Children's tests COVID-19 diagnostic tests for the NIH
Children’s, Emory University and Georgia Tech were selected to verify COVID-19 diagnostic tests from across the nation that were submitted for the RADx Program through the National Institutes of Health (NIH).
-
COVID-19 Biomarker Discovery
No reliable biomarker for predicting COVID-19 and MIS-C severity was available until a serendipitous discovery was made by the Children’s Pediatric Neurotrauma Lab.
Recent Publications: See How Our COVID-19 Research Is Making an Impact

Unprecedented Discoveries, Global Impact
Researchers at Children’s and Emory have shown what it takes to combat a pandemic. Unprecedented discoveries in COVID-19 have had a global impact while our standard research program has continued to achieve significant milestones, including a $31 million grant for the Marcus Center for Pediatric Cellular Therapies.
Read Our Research Report
Receive our latest research and innovation updates straight to your inbox.
Research into COVID-19 is ongoing, with new discoveries coming at an unprecedented pace. To stay on top of research advancements at Children’s, sign up for our updates.
SUBSCRIBEContact Us 404-785-KIDS (5437)